Envío a todo Costa Rica por solo ₡1490 

Enviar a
Costa Rica
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Selecciona tu país

América

Europa

Resto del mundo

portada Theory of Drug Development (en Inglés)
Formato
Libro Físico
Editorial
Idioma
Inglés
N° páginas
261
Encuadernación
Tapa Blanda
ISBN13
9781138374683

Theory of Drug Development (en Inglés)

Eric B. Holmgren (Autor) · CRC Press · Tapa Blanda

Theory of Drug Development (en Inglés) - Holmgren, Eric B.

Libro Nuevo Importado
Envío: 6 a 8 días háb.
₡ 55.746
Costos de importación y 13% IVA incluídos en el precio ✅
Libro Nuevo

Quedan 10 unidades

₡ 55.746
Llega entre el 13 Jul y el 17 Jul a Costa Rica. Seleccionar ubicación

Reseña del libro "Theory of Drug Development (en Inglés)"

Theory of Drug Development presents a formal quantitative framework for understanding drug development that goes beyond simply describing the properties of the statistics in individual studies. It examines the drug development process from the perspectives of drug companies and regulatory agencies.By quantifying various ideas underlying drug development, the book shows how to systematically address problems, such as: Sizing a phase 2 trial and choosing the range of p-values that will trigger a follow-up phase 3 trial Deciding whether a drug should receive marketing approval based on its phase 2/3 development program and recent experience with other drugs in the same clinical area Determining the impact of adaptive designs on the quality of drugs that receive marketing approval Designing a phase 3 pivotal study that permits the data-driven adjustment of the treatment effect estimate Knowing when enough information has been gathered to show that a drug improves the survival time for the whole patient population Drawing on his extensive work as a statistician in the pharmaceutical industry, the author focuses on the efficient development of drugs and the quantification of evidence in drug development. He provides a rationale for underpowered phase 2 trials based on the notion of efficiency, which leads to the identification of an admissible family of phase 2 designs. He also develops a framework for evaluating the strength of evidence generated by clinical trials. This approach is based on the ratio of power to type 1 error and transcends typical Bayesian and frequentist statistical analyses.

Opiniones del libro

Preguntas frecuentes sobre el libro

Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes